Skip to main content
SpringerLink
Log in

Pfizer lowers price of Prevenar 13 in world's poorest countries

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Global Alliance for Vaccinations and Immunisations

  2. see PharmacoEconomics & Outcomes News 720 p1; 801085922

References

  1. Pfizer. Pfizer Commits to Further Reduce Price for Prevenar 13 in the Worlds Poorest Countries Through 2025. Media Release : 26 Jan 2015. Available from: URL: http://www.pfizer.com.

  2. Elder K, et al. MSF responds to Pfizer announcement of pneumococcal vaccine price reduction. Internet Document : 31 Jan 2015. Available from: URL: http://www.msf.org/article/msf-responds-pfizer-announcement-pneumococcal-vaccine-price-reduction.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pfizer lowers price of Prevenar 13 in world's poorest countries. PharmacoEcon Outcomes News 721, 3 (2015). https://doi.org/10.1007/s40274-015-1878-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-1878-3

Search

Navigation